Complications of labial minor salivary gland biopsy and comparison of complications in patients with and without primary Sjögren's syndrome

Yıl 2020, Cilt: 6 Sayı: 5, 508 - 516, 04.09.2020

Koray Ayar , Ali Doğan Adem Küçük , Recep Tunç

https://doi.org/10.18621/eurj.743915

Öz

Objectives: Labial minor salivary gland biopsy (MSGB) is a procedure in which complications such as bleeding, hematoma, numbness, wetness can be seen after the procedure. It is not known whether these complications have changed in patients with primary Sjögren's syndrome (PSS). The aim of this study is to investigate the frequency of complications after the labial MSGB and to investigate whether these complications has changed in PSS.

Methods: Participants with a preliminary diagnosis of PSS who underwent a labial MSGB without any suture were included in the study. One month after the procedure, the complication screening questionnaire was administered face-to-face interview or by telephone. All complications were compared between PSS and non-PPS groups.

Results: Complications screening questionnaire was applied to 99 participants (face to face with 79 participants and by telephone with 20 participants). After the procedure, 17.2% of the participants had uncomfortable bleeding, 2.0% had persistent numbness which continues more than 1 week and 1.0% had wetness and hematoma. Bleeding duration was more than 1 hour in 11.1% of the participants. Complications were not different between PSS and non-PSS groups (p > 0.05).

Conclusions: After the labial MSGB procedure without suturing, uncomfortable bleeding is frequent and the duration of bleeding is long, but complications other than bleeding are rare. The incidence of complications after labial MSGB procedure was not different in participants with PSS than in those without PSS.

Anahtar Kelimeler

Complications, labial minor salivary gland biopsy, primary Sjögren’s syndrome

Kaynakça

• 1. Alhajj M, Babos M. Physiology, Salivation. StatPearls. Treasure Island (FL), 2019.
• 2. Carr AJ, Ng WF, Figueiredo F, Macleod RI, Greenwood M, Staines K. Sjögren's syndrome – an update for dental practitioners. Br Dent J 2012;213:353-7.
• 3. Thoppay JR, De Rossi SS, Ciarrocca KN. Burning mouth syndrome. Dent Clin North Am 2013;57:497-512.
• 4. Hay CR. Acquired haemophilia. Baillieres Clin Haematol 1998;11:287-303.
• 5. Zhang W, Wang F, Wang H, Hua B, Feng X, Sun L. Severe thrombocytopenia in connective tissue diseases: a single-center review of 131 cases. Clin Rheumatol 2018;37:3337-44.
• 6. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjogren's disease. J Clin Pathol. 1968;21:656-60.
• 7. Berquin K, Mahy P, Weynand B, Reychler H. Accessory or sublingual salivary gland biopsy to assess systemic disease: a comparative retrospective study. Eur Arch Otorhinolaryngol 2006;263:233-6.
• 8. Friedman JA, Miller EB, Huszar M. A simple technique for minor salivary gland biopsy appropriate for use by rheumatologists in an outpatient setting. Clin Rheumatol 2002;21:349-50.
• 9. Saruhanoglu A, Atikler M, Ergun S, Ofluoglu D, Tanyeri H. Comparison of two different labial salivary gland biopsy incision techniques: a randomized clinical trial. Med Oral Patol Oral Cir Bucal 2013;18:e851-5.
• 10. Richards A, Mutlu S, Scully C, Maddison P. Complications associated with labial salivary gland biopsy in the investigation of connective tissue disorders. Ann Rheum Dis 1992;51:996-7.
• 11. Caporali R, Bonacci E, Epis O, Bobbio-Pallavicini F, Morbini P, Montecucco C. Safety and usefulness of minor salivary gland biopsy: retrospective analysis of 502 procedures performed at a single center. Arthritis Rheum 2008;59:714-20.
• 12. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
• 13. Pavlakis PP, Alexopoulos H, Kosmidis ML, Stamboulis E, Routsias JG, Tzartos SJ, et al. Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry 2011;82:798-802.
• 14. Sene D, Jallouli M, Lefaucheur JP, Saadoun D, Costedoat-Chalumeau N, Maisonobe T, et al. Peripheral neuropathies associated with primary Sjogren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy. Medicine (Baltimore) 2011;90:133-8.
• 15. Brito-Zeron P, Akasbi M, Bosch X, Bove A, Perez-De-Lis M, Diaz-Lagares C, et al. Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjogren's syndrome. Clin Exp Rheumatol 2013;31:103-10.
• 16. Urban PP, Keilmann A, Teichmann EM, Hopf HC. Sensory neuropathy of the trigeminal, glossopharyngeal, and vagal nerves in Sjogren's syndrome. J Neurol Sci 2001;186:59-63.
• 17. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, et al. The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain 2005;128(Pt 11):2518-34.